Neuro-ophthalmic sarcoidosis: The University of Iowa experience

Seminars in Ophthalmology

Volumn 23, Issue 3, 2008, Pages 157-168

  Koczman, Jacob J ^a   Rouleau, Jacinthe ^b   Gaunt, Morgan ^c   Kardon, Randy H ^a   Wall, Michael ^a   Lee, Andrew G ^a,d  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d Department of Ophthalmology   (United States)

Author keywords

Neurosarcoid; Optic neuropathy; Sarcoidosis

Indexed keywords

CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; DIPEPTIDYL CARBOXYPEPTIDASE; GALLIUM; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ADULT; AFRICAN AMERICAN; AGED; ANISOCORIA; ARTICLE; BIOPSY; BRAIN RADIOGRAPHY; BRAIN REGION; CAUCASIAN; CAVERNOUS SINUS; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORTICOSTEROID THERAPY; DATA BASE; DEMOGRAPHY; DISEASE COURSE; ENZYME BLOOD LEVEL; FEMALE; FOLLOW UP; GRANULOMA; HORNER SYNDROME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG FUNCTION TEST; LUNG LAVAGE; MALE; MEDICAL RECORD; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC CHIASM; OPTIC DISK ANOMALY; OPTIC NERVE; OPTIC NERVE DISEASE; OPTIC TRACT; PALLOR; PAPILLEDEMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SARCOIDOSIS; THORAX RADIOGRAPHY; UNITED STATES; UNIVERSITY HOSPITAL; VISUAL ACUITY;

ADULT; AGED; AGED, 80 AND OVER; EYE DISEASES; FEMALE; GLUCOCORTICOIDS; HUMANS; INCIDENCE; IOWA; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NERVOUS SYSTEM DISEASES; PAPILLEDEMA; RETROSPECTIVE STUDIES; SARCOIDOSIS; TOMOGRAPHY, X-RAY COMPUTED; VISION DISORDERS;

EID: 42449146661     PISSN: 08820538     EISSN: 17445205     Source Type: Journal    
DOI: 10.1080/08820530802007382     Document Type: Article

References (41)

1. Longscope W, Frieman D. A study of sarcoidosis based on a combined investigation of 160 cases including 30 autopsies from the Johns Hopkins Hospital and Massachusetts General Hospital. Medicine 1952; 31:1-142.
2. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160:736-55.
3. James GD. Sarcoidosis and Other Granulomatous Disorders New York: Marcel Dekker, 1994.
4. Cummings MM, Dunner E, Schmidt HJ, et al. Concepts of epidemiology of sarcoidosis: preliminary report of 1,194 cases reviewed with special reference to geographic ecology. Postgrad Med 1956; 19:437-46.
5. Ricker W, Clark M. Sarcoidosis: a clinicopathological review of three hundred cases including 22 autopsies. Am J Clin Pathol 1949; 19:725-49.
6. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145:234-41.
7. Maycock RI, Bertrand P, Morrison CE, Scott JH. Manifestations of sarcoidosis: analysis of 145 patients with review of nine series selected from the literature. Am J Med 1963; 35:67-89.
8. Siltzbach LE, James DG, Neville E et al. Course and prognosis of sarcoidosis around the world. Am J Med 1974; 57:847-52.
9. Keller AZ. Hospital, age, racial, occupational, geographical, clinical and survivorship characteristics in the epidemiology of sarcoidosis. Am J Epidemiol 1971; 94:222-230.
10. McNicol MW, Luce PJ. Sarcoidosis in a racially mixed community. J R Coll Physicians Lond 1985; 19:179-83.
11. Frohman LP, Grigorian R, Bielory L. Neuro-ophthalmic manifestations of sarcoidosis: clinical spectrum, evaluation, and management. J Neuro-Ophthalmol. 2001; 21:132-37.
12. Frohman LP, Guirgis M, Turbin RE, Bielory L. Sarcoidosis of the anterior visual pathway: 24 new cases. J Neuroophthalmol 2003; 23:187-9.
13. Heuser K, Kerty E. Neuro-ophthalmological findings in sarcoidosis. Acta Ophthalmol Scand 2004; 82:723-9.
14. Lamirel C, Badelon I, Gout O, et al. Neuro-ophthalmologic initial presentation of sarcoidosis. J Fr Ophtalmol 2006; 29:241-9.
15. United States Census Bureau. 2001 Profiles of General Demographic Characteristics: 2000 Census of Population and Housing. Available at: http://factfinder.census.gov. Accessed September 21, 2007.
16. United States Census Bureau. 2006 American Community Survey. Available at: http://factfinder.census.gov. Accessed September 21, 2007.
17. Fanburg BL. Sarcoidosis and Other Granulomatous Diseases of the Lung. New York: Marcel Dekker. 1983, 37-75.
18. Maycock RI, Bertrand P, Morrison CE, Scott JH. Manifestations of sarcoidosis: analysis of 145 patients with review of nine series selected from the literature. Am J Med 1963; 35:67-89.
19. Delaney P. Neurologic manifestations in sarcoidosis: review of the literature, with a report of 23 cases. Ann Intern Med 1977; 87:336-45.
20. Stern BJ, Krumholz A, Johns C, et al. Sarcoidosis and its neurological manifestations. Arch Neurol 1985; 42:909-17.
21. Gullapalli D, Phillips LH. Neurologic manifestation of sarcoidosis. Neurol Clin 2002; 20:59-83.
22. Christoforidis GA, Spickler EM, Recio MV, et al. MR of CNS sarcoidosis: correlation of imaging features to clinical symptoms and response to treatment. AJNR Am J Neuroradiol 1999; 20:655-9.
23. Hayes WS, Sherman JL, Stern BJ, et al. MR and CT evaluation of intracranial sarcoidosis. Am J Roentgenol 1987; 149:1043-9.
24. Zajicek JP, Scolding NJ, Foster O, et al. Central nervous system sarcoidosis-diagnosis and management. QJM 1999; 92:103-17.
25. Oksanen V. Neurosarcoidosis: clinical presentation and course in 50 patients. Acta Neurol Scand 1986; 73:283-90.
26. Chapelon C, Ziza JM, Piette JC, et al. Neurosarcoidosis: signs, course and treatment in 35 confirmed cases. Medicin 1990; 69:261-76.
27. Spencer TS, Campellone JV, et al. Clinical and magnetic resonance imaging manifestations of neurosarcoidosis. Semin Arthritis Rheum 2005; 34:649-61.
28. Oksanen V, Grönhagen-Riska C, Fyhrquist F, Somer H. Systemic manifestations and enzyme studies in sarcoidosis with neurologic involvement. Acta Med Scand 1985; 218:123-7.
29. Sharma OP. Neurosarcoidosis: a personal perspective based on the study of 37 patients. Chest 1997; 112:220-8.
30. Ferriby D, de Seze J, Stojkovic T, et al. Long-term follow-up of neurosarcoidosis. Neurology 2001; 57:927-9.
31. Lower EE, Broderick JP, Brott TG, Baughman RP. Diagnosis and management of neurological sarcoidosis. Arch Intern Med 1997; 157:1864-8.
32. Wiederholt WC, Siekert RG. Neurological manifestation of sarcoidosis. Neurology 1965; 15:1147-54.
33. Kellinghaus C, Schilling M, Lüdemann P. Neurosarcoidosis: clinical experience and diagnostic pitfalls. Eur Neurol 2004; 51:84-8.
34. Allen RK, Sellars RE, Sandstrom PA. A prospective study of 32 patients with neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20:118-25.
35. Jabs DA, Johns CJ. Ocular involvement in chronic sarcoidosis. Am J Ophthalmol 1986; 102:297-301.
36. Beardsley TL, Brown SV, Sydnor CF, et al. Eleven cases of sarcoidosis of the optic nerve. Am J Ophthalmol 1984; 97:62-77.
37. Lynch JP. Neurosarcoidosis: how good are the diagnostic tests? J Neuro-ophthalmol 2003; 23:187-9.
38. Carmody RF, Mafee MF, Goodwin JA, et al. Orbital and optic pathway sarcoidosis: MR findings. Am J Neuroradiol. 1994; 15:775-83.
39. Marangoni S, Argentiero V, Tavolato B. Neurosarcoidosis: clinical description of 7 cases with a proposal for a new diagnostic strategy. J Neurol 2006; 253:488-95.
40. Lynch JP 3rd, Ma YL, Koss MN, White ES. Pulmonary sarcoidosis. Semin Respir Crit Care Med. 2007; 28:53-74.
41. Stern BJ, Corbett J. Neuro-ophthalmologic manifestations of sarcoidosis. Curr Treat Options Neurol 2007; 9:63-71.